Catalyst Wire Dossier Catalyst Wire Dossier

MORAb-009

farletuzumab · Morphotek
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MORAb-009, covering 2014-07-17 to 2016-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MORAb-009 in Patients With Solid Tumor [Phase 1]

See pricing